COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Effects of Phenolic Acids on Endothelial Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01772784
Recruitment Status : Completed
First Posted : January 21, 2013
Last Update Posted : January 21, 2013
Information provided by (Responsible Party):

Brief Summary:
Epidemiological studies suggest dietary (poly) phenols decrease the risk of death from cardiovascular diseases. (Poly)phenol-rich foods include fruits and vegetables as well as tea, coffee, red wine, and chocolate. The aim of the present study is to investigate whether endothelial function is altered by ingestion of phenolic acids. Moreover, the investigators will evaluate the effect of phenolic acids on blood pressure and platelet adhesion.

Condition or disease Intervention/treatment Phase
Healthy Other: Phenolic acids Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Study Start Date : June 2012
Actual Primary Completion Date : November 2012
Actual Study Completion Date : November 2012

Arm Intervention/treatment
Experimental: phenolic acids
Maltodextrine + Phenolic acids
Other: Phenolic acids
Phenolic acids

Placebo Comparator: placebo
Other: Phenolic acids
Phenolic acids

Experimental: phenolic acid
Maltodextrine + Phenolic acids
Other: Phenolic acids
Phenolic acids

Active Comparator: polyphenol Other: Phenolic acids
Phenolic acids

Primary Outcome Measures :
  1. endothelial dysfunction [ Time Frame: 1 hour ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy
  • males
  • Smokers

Exclusion Criteria:

Any food allergy

  • Abnormal blood pressure defined as follow: systolic <100 or >160 mmHg and diastolic <50 or >100mmHg
  • Regular consumption of medication within 2 months before the study inclusion
  • Caffeine intake 1 day before screening measurements (and 1 day before each visit),
  • Any intake of multivitamin-tablets and other supplemental compounds 10 days before the study start and throughout the study.
  • Excessive alcohol intake defined as > 280 g per week

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01772784

Layout table for location information
Swiss Cardiovascular Center Bern, University Hospital
Bern, Switzerland, 3010
Sponsors and Collaborators
Layout table for investigator information
Principal Investigator: Yves Allemann, MD, Prof. University Hospital, Bern, Switzerland

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Nestlé Identifier: NCT01772784    
Other Study ID Numbers: 11.36.NRC
First Posted: January 21, 2013    Key Record Dates
Last Update Posted: January 21, 2013
Last Verified: November 2012
Keywords provided by Nestlé: